chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Next day 04/08/2021 afternoon fever range 100.6.-101.6, extreme fatigue ,vaccination arm location swollen to size of egg- currently size of marble,; pain in wrist by thumb, shoulders and neck . Ongoing  from 04/08/2021 to current day, 21 days so far. Verbally evaluated the signs and symptoms prescribed meloxicam 7.5 mg twice a day and headaches, pharmacist states once a day for the meloxicam 7.5. Not resolved currently still having  burning and occasional lighting bolt of extreme pain and the marble size knot in the left arm of vaccination location.
Initial report received on 17 March 2009 from a literature collection. " A previously healthy 17 month old boy was inoculated with FLUZONE SV '2005-'2006 USP (lot number U1804AA) by intramuscular injection. Three weeks later, when he was otherwise well and did not appear to be in pain, his mother noted that he was esotropic. There was no history of antecedent febrile illness, trauma, or family history of strabismus. Ophthalmic examination, revealed a 45 degree esotropia in primary gaze increasing to a 65 degree esotropia in right gaze and orthotropia in left gaze. Examination of ductions revealed marked limitation of abduction of the right eye and full ductions of the left eye, consistent with right lateral rectus paralysis. Cycloplegenic refraction revealed +1.5 D spherical error for each eye. The remainder of the ophthalmic examination, including dilated fundus examination, was normal. A complete neurological examination was unremarkable. Magnetic resonance imaging (MRI) was performed, including T1, T2 fluid attenuation inversion recovery (FLAIR), and fat saturation views of the brain and orbits. Gadolinium-enhanced imaging used 3 mm slices without interslice gap and non enhanced imaging used 1 mm slice resolution of the brain and orbits. Fast imaging used 1 mm slice resolution of the brain and orbits. Fast imaging using steady state acquisition sequencing was used to achieve submillimter resolution in assessing the course of the sixth nerve from the ventral medulla into the cavernous sinus and orbit. Neuroimaging did not reveal any abnormality. Part-time occlusion therapy of his left eye was instituted, and repeat examination at 4 months revealed a 15 degree esotropia in primary gaze with improved abduction of the right eye. Subsequent examinations revealed orthotropia in primary gaze and a 10 degree esotropia in right gaze with minimal limitation of abduction of the right eye at 6 months and orthotropia in all diagnostics positions of gaze at 9 months at which time occlusion therapy was discontinued. The child was then well until 1 year after the onset of symptoms when 3 weeks after receiving FLUZONE (lot number U2174GA), his esotropia recurred. He otherwise appeared well and did not appear to be in pain. He exhibited a 10 to 20 degree incomitant esotropia with limitation of abduction of the right eye. The patient was orthotropic in levoversion. The remainder of the ophthalmic examination was unremarkable. A neurological examination and MRI of the brain and orbits without gadolinium failed to reveal any abnormalities. Repeat examination at 6 weeks demonstrated orthotropia in primary and left gaze, and a 10 degree esotropia in right gaze. The residual motility deficit failed to resolve over the subsequent 7 months." 27 March 2009: A corrective version with the latest received date of the previous version, 17 March 2009, was created in order to add the second dose of FLUZONE to the case. The reporter of this case is the same as case number 2009-01134. List of Documents held by Sender: none.
When I came home, I was running a fever, dizzy, sore throat and lost my voice, developed a rash on my right side, body aches. Today I have about a 2?x1? welt at the site of injection and my arm is so sore I can barely move it.
Patient notice nausea and weakness but also told me he told a Venlafaxine 75mg tablet which can also present those reactions.
headache and stomachache for 3 days, passed out at 1:30 AM Feb. 11.  Life squad called BP 90/60.  Swelling of left upper arm, swollen lymph node under left arm that lasted 4 days
Initial response was severe fatigue which lasted 4 or 5 days, the second or third day the already existing SOB from covid became increasingly worse and to this day continues.  There is also a cough that resulted from the covid today that continues.  Currently the cough continues, the SOB continues but is slowly getting better and the fatigue continues although I continue to work.  I feel the fatigue that working with the other symptoms certainly contributes.  I am also beginning to have lower leg cramps that I have not seen Dr for.
INDURATION AND ERYTHEMA AT THE SITE OF INJECTION.  INDURATION- 30 *30 ERYTHEMA- 60 * 60
Fever, chills, headache, body aches, nausea, diarrhea, pain at injection site.  Two days later I still have all symptoms except fever. Getting better but had to leave work early today.
Sensorineural hearing loss - right ear- muffled hearing. Noticed within approximately 90 minutes of injection. Next day (today)- hearing is still muffled- but seems to be improving.
Patient reacted to Varivax vaccine within the first 10 minutes of vaccination. A welt rose on patient's left arm, patient stated she felt dizzy and had trouble breathing; patient was also very scared. Vaccine was given at 10:35, by 10:40 patient's guardian reported a reaction, by 10:45 Dr., MD (pediatrician) was assessing the patient. Patient was instructed to lay down and instructed through breathing exercises. Patient given PO liquid Benadryl per the MD; no epinephrine was warranted per the MD.
General Fatigue lasting 24 hours Shot site soreness - ongoing Pain in underarm of arm that received shot from lymph node swelling - ongoing
Patient called pharmacy on 12/27/21 stating that she had side effects from her booster dose. She reported very high blood pressure that started occurring on 12/23/21 (vaccine given 12/22/21). Patient reported the following readings:  182/86, 170/94, 181/92, 188/93. Patient also reported developing a rash on her arm around the injection site. Patient said she was going to her doctor 12/27/21.
Patient administered incorrect vaccine by a provider (different provider than the individual completing this form). Patient was 5 years of age at the time of administration. He received Pfizer maroon cap (6mo-4yo) 3mcg/0.2mL dose instead of Pfizer orange cap (5yo-11yo) 10mcg/0.2mL.
Last week patient mentioned that he was getting a rash on his chest. Rash is small oddly shaped reddish and raised. The rash is not too itchy unless he gets hot and sweaty. The rash has gotten worse in the week since he first reported it. It occured to me today that this might be an adverse reaction to this vaccine. I am aware that this rash may also not be related to the vaccination but I wanted to have it documented in case he has any further issues. We have been putting a general antibiotic ointment on the worst of the sores. We have not sought out medical attention yet in the hopes that it will clear up on its own.
Pain and redness over left deltoid occurring hours following vaccination and persists for eight days following vaccination. Pain in anterior chest near clavicle.  Upset stomach one day following vaccination resolved,  Headache following vaccination, headache off and on since vaccination.
Extreme joint aches, headaches, tiredness, nausea, dizziness.  All symptoms except nausea lasted one week.  I am still experiencing slight nausea and am only eating bland, soft food.  I have lost 6 pounds.
Experiencing signs/symptoms of stroke and was rushed to the ER where he was hospitalized; Numbness on left side of body; Swelling of the lymph nodes; Intense headache; muscle pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CEREBROVASCULAR ACCIDENT (Experiencing signs/symptoms of stroke and was rushed to the ER where he was hospitalized), HYPOAESTHESIA (Numbness on left side of body), LYMPHADENOPATHY (Swelling of the lymph nodes), HEADACHE (Intense headache) and MYALGIA (muscle pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CEREBROVASCULAR ACCIDENT (Experiencing signs/symptoms of stroke and was rushed to the ER where he was hospitalized) (seriousness criterion hospitalization), HYPOAESTHESIA (Numbness on left side of body) (seriousness criterion hospitalization prolonged), LYMPHADENOPATHY (Swelling of the lymph nodes) (seriousness criterion hospitalization prolonged), HEADACHE (Intense headache) (seriousness criterion hospitalization prolonged) and MYALGIA (muscle pain) (seriousness criterion hospitalization prolonged). At the time of the report, CEREBROVASCULAR ACCIDENT (Experiencing signs/symptoms of stroke and was rushed to the ER where he was hospitalized), HYPOAESTHESIA (Numbness on left side of body), LYMPHADENOPATHY (Swelling of the lymph nodes), HEADACHE (Intense headache) and MYALGIA (muscle pain) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: negative (Negative) Negative. On an unknown date, Electrocardiogram: negative (Negative) Negative. On an unknown date, Magnetic resonance imaging: negative (Negative) Negative. On an unknown date, Ultrasound scan: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medicines were not included, Treatment medicines were not provided.  Company comment: This case concerns an adult male hospitalized with serious unexpected symptoms of cerebrovascular accident, headache, hypoesthesia, myalgia, lymphadenopathy. Event onset with unknown latency after first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns an adult male hospitalized with serious unexpected symptoms of cerebrovascular accident, headache, hypoesthesia, myalgia, lymphadenopathy. Event onset with unknown latency after first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
pt recv vax 12JAN96 & 1mo later pt slipped on ice & landed on lt arm & shoulder;since then pt has had pain in area, but particularly @ inj site;also reported a red streak @ inj site;MD visit was required;pt has been taking NSAID for pain;
After experiencing the usual redness, swelling and itching for three days, all was well. Woke up this morning with a bright red dot at the injection site, minor swelling and itching.
Shot given 0815, Experienced Redness, pain, itching at injection site and numbness/tingling down left arm around 0930.
History of COVID-19 infection in December 2021, mild case-fully recovered at time of immunization.  Vaccinated for COVID-19 in March 2022. Palpitations primarily exertional, particularly with short bursts of high intensity exercise, as opposed to lengthier cardio events. Palpitations make him feel like he needs to cough, which usually helps stop the episode. Also having occasional episodes of dull left-sided chest pains at rest, lasting <30 minutes. This also began 1-2weeks after receiving the J&J vaccine and has been occurring 3-4x/week. Has upcoming ECHO, Zio patch and ECHO scheduled.
2 days after Dtap site became hot, hard, red in oval from elbow to shoulder (right upper arm). Pt affected droopy. Dr called by mom, antibiotic prescribed oral, resolved.
Swelling, pain, erythema, warmth and vesicles in the deltoid area of injection.
chills, bodyaches, redness and swelling that is still present 5 days after administration. Per the patient, she is a nurse and it looks like cellulitis and the redness is spreading
Febrile seizure around 6pm on March 12th, 9 days after MMR and Pediarix administration. Child stated his head and belly hurt and asked to go lay down. Temporal temperature 99.9 with sudden onset. Ten minutes later child vomited and a seizure with focal activity began. Body became flaccid, both eyes and head drifted to left with a head tick. Child was drooling profusely and unresponsive to commands for around 5-7 minutes.  Paramedics were called and arrived around ten minutes later after seizure activity had stopped.  Child was sleepy, tachycardic, still unresponsive to commands and not speaking. He was transported to pediatric emergency department for observation and testing. Blood glucose 99. Influenza and Strep tests negative. Red rash on face, trunk and arms.
sore arm for 1 day after; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 6 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Nov2021 18:15 (Batch/Lot number: unknown) at the age of 6 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "seasonal allergies" (unspecified if ongoing). There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 10Nov2021 06:45, outcome "recovered" (10Nov2021), described as "sore arm for 1 day after". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: No other vaccine in four weeks, no other medications in two weeks, no treatment ae, no covid prior vaccination, no covid tested post vaccination. There was known allergies: seasonal allergies and no other medical history.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
left 1st, 2nd toes were red and swollen; left 1st, 2nd toes were red and swollen; left 1st, 2nd, and 3rd toes that blanched more easily; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SWELLING (left 1st, 2nd toes were red and swollen), ERYTHEMA (left 1st, 2nd toes were red and swollen) and PALLOR (left 1st, 2nd, and 3rd toes that blanched more easily) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 012L20A) for COVID-19 vaccination.     The patient's past medical history included Raynauds. Concurrent medical conditions included Penicillin allergy and Hypertension since 05-Jul-1980. Concomitant products included VITAMIN D3 from 04-Jan-2019 to an unknown date for Immune imbalance, VITAMINS NOS (DAILY MULTIVITAMIN) from 09-Jan-1980 to an unknown date for Vitamin supplementation.   On 14-Jan-2021 at 9:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced SWELLING (left 1st, 2nd toes were red and swollen) and ERYTHEMA (left 1st, 2nd toes were red and swollen). 11-Mar-2021, the patient experienced PALLOR (left 1st, 2nd, and 3rd toes that blanched more easily). On 17-Apr-2021, SWELLING (left 1st, 2nd toes were red and swollen) and ERYTHEMA (left 1st, 2nd toes were red and swollen) had resolved. At the time of the report, PALLOR (left 1st, 2nd, and 3rd toes that blanched more easily) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient's dermatologist recommended clotrimazole on 11mar2021. Her podiatrist changed treatment to triamcinolone 0.1% ointment, "that was helpful."
patient was administered the PENTACEL however only the DTAP/IPV component, not the ACT-HIB portion (with no reported adverse event); Initial information received on 23-Aug-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 1 years old female patient who was administered the Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine [Pentacel (VERO)] however only the dtap/ipv component, not the act-hib portion (with no reported adverse event).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 22-Aug-2023, the patient received a 0.5 ml dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine Suspension for injection (lot U7311A, expiry date: 09-Sep-2023 with unknown strength) via intramuscular route in left thigh as Immunization.  On 22-Aug-2023 (Latency: same day) the patient was administered the Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine  however only the dtap/ipv component, not the act-hib portion (with no reported adverse event) (single component of a two-component product administered) (unknown latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
pt began w/red flat blotches on face, chest & back; temp 97.2 axillary; pt was smiling & playing
whole body hives; Initial information received on 11-Oct-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves male patient of an unknown age who experienced whole body hives (urticaria), while he received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious whole body hives (urticaria) (Unknown latency) following the administration of INFLUENZA VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was whole body hives.  It was not reported if the patient received a corrective treatment.  The outcome of the event was Unknown for whole body hives.  Information on the batch number was requested
Swelling in lower right leg, ankle, foot; Venous Doppler ordered; blood clot detected; doctor examination; Eliquis prescribed.
Cold/ cold like symptoms; Sore throat; Congested/ sore throat; Sore arm; I was hurting for a day; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) intramuscular on left arm at single dose for COVID-19 immunization on 23Dec2020 at 61-year-old. No medical history or concomitant medication. Yesterday (30Dec2020), the patient woke up with a sore throat, it was like getting cold with a sore throat, congested, the patient had cold like symptoms, seemed like the patient was getting a cold. The patient just took decongestant medication. After waking up this morning (31Dec2020) the patient did not have taken anything. The patient got tested for COVID (for antigen not a PCR) yesterday (30Dec2020) and was negative. The patient did not have got any fever, just sore arm a week ago (Dec2020). She was hurting for a day and then she was good, everything good. Action taken for BNT162B2 was not applicable. Outcome of the events was unknown.
Loss of mobility in left arm  Pain + swelling. Patient received range of motion exercises to complete daily. Still have pain, but better range of motion on 9/28/20
Apart of the Moderna Trial.  First reaction 12/27/2021  and you confirmed it on 12/28/2021 with the compund drug issues by taking the directic that she had been taken for a year and she had a reaction, to compound drug medication, the reation was to the micro cyristiyln ciolousis.  Medication is compounded drug wth two ingrediates. The issue occurred with the throut tighting and flushing.  Moderna 3; 10/30/2021.  Migrain headache and new   mass cell activation issue. that is brand trying to get appointment to get it evaluated and self treating with antihesime over the conter 10mg a day. Stop taking drugs from 12/29/2021 thru 01/09/2022 to try to figure out what was going on. Started the Antihystimine on the 01/10/2022 with her regular medicine . After a full week symptions improved and went a way gradually. Antihispheme Loratadine  10mg once a day.  - the new Loratadine  10mg once a day is helping to mantain a positive control of condition. Consultation with Phramacist was not able to get into the doctors.
Myalgia DAY 2: BODYACHE RESOLVED BY THE END OF THE DAY
Site: Swelling at Injection Site-Medium, Additional Details: PATIENT STATED THAT SHE HAD A SORE ARM AT THE INJECTION SITE SINCE 1/18/23 OF IMMUNIZATION.